Transparency Market Research presents this most up-to-date research on “Scaffold Technology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024“
Scaffolds are artificial extracellular matrices that support 3D tissue regenerations and accommodate cells. These can be temporary or permanent matrices which provide chemical, mechanical, and biological support for tissue formation. Scaffold technology is employed to perform 3D culture assays that include cell to cell interactions, high throughput screening, cell to matrix interactions, transfections, and cell migration assays. Growing regenerative technology has been attributed to the growth of the scaffold technology market which has led to the development of bio-scaffolds. Scaffolds act as a template for tissue formation, which are subject to biophysical stimuli through a bioreactor, a system which applies chemical and mechanical stimuli to the cells; or are provided with growth factors.
In terms of material, the scaffold technology market can be segmented into bio-inert, bioresorbable, and bioactive. Based on technology, the market can be segmented into nanofiber-based scaffolds, polymeric scaffolds, hydrogels, and micro-patterned surface microplates. In terms of application, the scaffold technology market can be segmented into drug development, tissue culture, cancer treatment, stem cell research, and regenerative technology. End-users in the scaffold technology market include biotechnology and pharmaceutical organizations, research laboratories, hospitals, and diagnostic laboratories. In terms of region, the market can be segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa.
Browse Global Strategic Business Report:
Scaffold technology provides opportunities to address the challenges associated with tissue culture such as vascularization and enable organ implant regeneration employed in the treatment of damaged and diseased organs or tissues. Increasing number of applications would contribute to the growth of scaffold technology market. In addition, rising accidents leading to organ damage and increase in geriatric population that add to the rising number of people with non-functioning of organs contribute to the growth of the scaffold technology market. In addition, ongoing research on designing matrix-based 3D substrates that enable interaction between implants and host microenvironment for optimal functioning of the implanted cells and drug release is expected to boost the market in terms of revenue during the forecast period. However, the emergence of scaffold-free technology for cell culturing is expected to hamper the scaffold technology market during the forecast period.
Hydrogels based scaffolds are expected to dominate the scaffold technology market due to the continuous progress in their development. However, nanofiber-based scaffolds are expected to record highest growth rate during the forecast period, owing to the growing nanotechnology and their ability to mimic nanoscale properties. Growing investments by biotechnology companies for the development of products related to scaffold technology is expected to contribute to the growth of the scaffold technology market.
North America is expected to dominate the scaffold technology market. Growth of the market in the region can be attributed to well-developed infrastructure in the region, ongoing research, and the presence of major market players in the region. However, the scaffold technology market in Asia Pacific is expected to record the highest growth rate during the forecast period, owing to the increasing government focus on boosting research and development in the pharmaceutical industry and the improving health care infrastructure in the region.
Leading players in the scaffold technology market include 3D Biomatrix, 3D Biotek LLC, Acelity (LifeCell Corporation), Avacta Life Sciences Limited, Becton, Dickinson and Company, Medtronic (Covidien plc), Merck KGaA (Sigma-Aldrich Co. LLC), Molecular Matrix, Inc., Molecular Partners, Nanofiber Solutions, NuVasive, Inc., Pelo Biotech GmbH, ReproCELL Europe Ltd. (Reinnervate), Thermo Fisher Scientific, Inc., Vericel Corporation, and Xanofi. The leading players in the market have been focusing on diversifying their product portfolios and expanding their distribution networks to strengthen their market position.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Download Exclusive Brochure of This Report :
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453